Ramipril substantially improved walking times in PAD trial
After six months, patients with peripheral artery disease and intermittent claudication who were treated with ramipril were able to walk considerably longer pain free and walk much farther on a treadmill compared with their peers who received placebo, in a new study. The gains were greater than typical improvements associated with the two drugs that are currently approved in the US for PAD. (Source: theHeart.org)
Source: theHeart.org - February 5, 2013 Category: Cardiology Source Type: news
Walking Time in PAD Better with ACE Inhibitor (CME/CE)
(MedPage Today) -- Walking duration and pain-free walking both improved significantly in patients with claudication after treatment with the ACE inhibitor ramipril, a randomized trial showed. (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - February 5, 2013 Category: Cardiology Source Type: news
Ramipril Improves Walking Times in Patients with Intermittent Claudication
(Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - February 5, 2013 Category: Primary Care Tags: Medical News Source Type: news
